# Bandwidth Inc.: financial statements, quarterly

BAND · Nasdaq · CIK 1514416 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/band.md) · [Financials](/companies/band/financials.md) · [Filings](/companies/band/filings.md) · [Insiders](/companies/band/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/band/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [146](/filings/0001514416-24-000140.md) | [152](/filings/0001514416-24-000173.md) | [165 d](/filings/0001514416-26-000017.md) | [171](/filings/0001514416-25-000072.md) | [174](/filings/0001514416-25-000111.md) | [194](/filings/0001514416-25-000121.md) | [210 d](/filings/0001514416-26-000017.md) | [174](/filings/0001514416-26-000035.md) | [180](/filings/0001514416-25-000111.md) | [192](/filings/0001514416-25-000121.md) | [208 d](/filings/0001514416-26-000017.md) | [209](/filings/0001514416-26-000035.md) |
| Cost of revenue | $m | [86.9](/filings/0001514416-24-000140.md) | [92.5](/filings/0001514416-24-000173.md) | [103 d](/filings/0001514416-26-000017.md) | [106](/filings/0001514416-25-000072.md) | [109](/filings/0001514416-25-000111.md) | [121](/filings/0001514416-25-000121.md) | [133 d](/filings/0001514416-26-000017.md) | [103](/filings/0001514416-26-000035.md) | [108](/filings/0001514416-25-000111.md) | [118](/filings/0001514416-25-000121.md) | [130 d](/filings/0001514416-26-000017.md) | [131](/filings/0001514416-26-000035.md) |
| Gross profit | $m | [59.0](/filings/0001514416-24-000140.md) | [59.5](/filings/0001514416-24-000173.md) | [62.1 d](/filings/0001514416-26-000017.md) | [65.5](/filings/0001514416-25-000072.md) | [64.8](/filings/0001514416-25-000111.md) | [73.1](/filings/0001514416-25-000121.md) | [76.5 d](/filings/0001514416-26-000017.md) | [71.5](/filings/0001514416-26-000035.md) | [71.7](/filings/0001514416-25-000111.md) | [73.8](/filings/0001514416-25-000121.md) | [78.1 d](/filings/0001514416-26-000017.md) | [77.9](/filings/0001514416-26-000035.md) |
| Research and development | $m | [24.9](/filings/0001514416-24-000140.md) | [24.8](/filings/0001514416-24-000173.md) | [28.9 d](/filings/0001514416-26-000017.md) | [28.9](/filings/0001514416-25-000072.md) | [28.1](/filings/0001514416-25-000111.md) | [30.2](/filings/0001514416-25-000121.md) | [31.4 d](/filings/0001514416-26-000017.md) | [30.6](/filings/0001514416-26-000035.md) | [31.7](/filings/0001514416-25-000111.md) | [33.0](/filings/0001514416-25-000121.md) | [37.1 d](/filings/0001514416-26-000017.md) | [38.5](/filings/0001514416-26-000035.md) |
| Operating income | $m | [(7.5)](/filings/0001514416-24-000140.md) | [(6.1)](/filings/0001514416-24-000173.md) | [(10.0) d](/filings/0001514416-26-000017.md) | [(10.4)](/filings/0001514416-25-000072.md) | [(6.1)](/filings/0001514416-25-000111.md) | [(0.9)](/filings/0001514416-25-000121.md) | [(2.7) d](/filings/0001514416-26-000017.md) | [(4.7)](/filings/0001514416-26-000035.md) | [(3.7)](/filings/0001514416-25-000111.md) | [(2.0)](/filings/0001514416-25-000121.md) | [(3.9) d](/filings/0001514416-26-000017.md) | [(4.6)](/filings/0001514416-26-000035.md) |
| Income tax | $m | [0.2](/filings/0001514416-24-000140.md) | [(0.2)](/filings/0001514416-24-000173.md) | [0.2 d](/filings/0001514416-26-000017.md) | [(0.2)](/filings/0001514416-25-000072.md) | [(0.3)](/filings/0001514416-25-000111.md) | [(0.7)](/filings/0001514416-25-000121.md) | [(1.2) d](/filings/0001514416-26-000017.md) | [(0.1)](/filings/0001514416-26-000035.md) | [0.1](/filings/0001514416-25-000111.md) | [(2.3)](/filings/0001514416-25-000121.md) | [(1.5) d](/filings/0001514416-26-000017.md) | [(1.5)](/filings/0001514416-26-000035.md) |
| Net income | $m | [(3.9)](/filings/0001514416-24-000173.md) | [(5.1)](/filings/0001514416-24-000173.md) | [(10.9)](/filings/0001514416-24-000173.md) | [(9.2)](/filings/0001514416-25-000121.md) | [4.1](/filings/0001514416-25-000121.md) | [0.4](/filings/0001514416-25-000121.md) | [(1.8)](/filings/0001514416-25-000121.md) | [(3.7)](/filings/0001514416-26-000035.md) | [(4.9)](/filings/0001514416-26-000035.md) | [(1.2)](/filings/0001514416-26-000035.md) | [(3.0)](/filings/0001514416-26-000035.md) | [4.1](/filings/0001514416-26-000035.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001514416-24-000140.md) | [(0.20)](/filings/0001514416-24-000173.md) | not reported | [(0.35)](/filings/0001514416-25-000072.md) | [(0.17)](/filings/0001514416-25-000111.md) | [0.01](/filings/0001514416-25-000121.md) | not reported | [(0.13)](/filings/0001514416-26-000035.md) | [(0.16)](/filings/0001514416-25-000111.md) | [(0.04)](/filings/0001514416-25-000121.md) | not reported | [(0.08)](/filings/0001514416-26-000035.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001514416-24-000140.md) | [(0.20)](/filings/0001514416-24-000173.md) | not reported | [(0.35)](/filings/0001514416-25-000072.md) | [0.15](/filings/0001514416-25-000111.md) | [0.02](/filings/0001514416-25-000121.md) | not reported | [(0.13)](/filings/0001514416-26-000035.md) | [(0.16)](/filings/0001514416-25-000111.md) | [(0.04)](/filings/0001514416-25-000121.md) | not reported | [0.13](/filings/0001514416-26-000035.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [91.8](/filings/0001514416-24-000140.md) | [107](/filings/0001514416-24-000173.md) | [132](/filings/0001514416-26-000017.md) | [105](/filings/0001514416-25-000072.md) | [62.0](/filings/0001514416-25-000111.md) | [74.9](/filings/0001514416-25-000121.md) | [81.8](/filings/0001514416-26-000017.md) | [35.9](/filings/0001514416-26-000035.md) | [60.1](/filings/0001514416-25-000111.md) | [73.4](/filings/0001514416-25-000121.md) | [103](/filings/0001514416-26-000035.md) | [47.3](/filings/0001514416-26-000035.md) |
| Current assets | $m | [220](/filings/0001514416-23-000123.md) | [234](/filings/0001514416-23-000151.md) | [253](/filings/0001514416-25-000024.md) | [257](/filings/0001514416-24-000083.md) | [181](/filings/0001514416-24-000140.md) | [199](/filings/0001514416-24-000173.md) | [188](/filings/0001514416-26-000017.md) | [151](/filings/0001514416-25-000072.md) | [176](/filings/0001514416-25-000111.md) | [193](/filings/0001514416-25-000121.md) | [219](/filings/0001514416-26-000035.md) | [172](/filings/0001514416-26-000035.md) |
| Total assets | $m | [917](/filings/0001514416-23-000123.md) | [1,070](/filings/0001514416-23-000151.md) | [1,101](/filings/0001514416-25-000024.md) | [1,086](/filings/0001514416-24-000083.md) | [1,002](/filings/0001514416-24-000140.md) | [1,030](/filings/0001514416-24-000173.md) | [989](/filings/0001514416-26-000017.md) | [964](/filings/0001514416-25-000072.md) | [1,022](/filings/0001514416-25-000111.md) | [1,033](/filings/0001514416-25-000121.md) | [1,053](/filings/0001514416-26-000035.md) | [984](/filings/0001514416-26-000035.md) |
| Current liabilities | $m | [97.8](/filings/0001514416-23-000123.md) | [109](/filings/0001514416-23-000151.md) | [123](/filings/0001514416-25-000024.md) | [109](/filings/0001514416-24-000083.md) | [156](/filings/0001514416-24-000140.md) | [154](/filings/0001514416-24-000173.md) | [140](/filings/0001514416-26-000017.md) | [116](/filings/0001514416-25-000072.md) | [135](/filings/0001514416-25-000111.md) | [139](/filings/0001514416-25-000121.md) | [154](/filings/0001514416-26-000035.md) | [183](/filings/0001514416-26-000035.md) |
| Total liabilities | $m | [625](/filings/0001514416-23-000123.md) | [790](/filings/0001514416-23-000151.md) | [804](/filings/0001514416-25-000024.md) | [787](/filings/0001514416-24-000083.md) | [695](/filings/0001514416-24-000140.md) | [693](/filings/0001514416-24-000173.md) | [677](/filings/0001514416-26-000017.md) | [619](/filings/0001514416-25-000072.md) | [638](/filings/0001514416-25-000111.md) | [641](/filings/0001514416-25-000121.md) | [653](/filings/0001514416-26-000035.md) | [579](/filings/0001514416-26-000035.md) |
| Long-term debt | $m | [418](/filings/0001514416-23-000123.md) | [418](/filings/0001514416-23-000151.md) | [419](/filings/0001514416-25-000024.md) | [419](/filings/0001514416-24-000083.md) | [281](/filings/0001514416-24-000140.md) | [281](/filings/0001514416-24-000173.md) | [281](/filings/0001514416-26-000017.md) | [247](/filings/0001514416-25-000072.md) | [247](/filings/0001514416-25-000111.md) | [247](/filings/0001514416-25-000121.md) | [248](/filings/0001514416-26-000035.md) | [149](/filings/0001514416-26-000035.md) |
| Shareholders' equity | $m | [292](/filings/0001514416-24-000173.md) | [280](/filings/0001514416-24-000173.md) | [297](/filings/0001514416-26-000017.md) | [298](/filings/0001514416-25-000121.md) | [307](/filings/0001514416-25-000121.md) | [337](/filings/0001514416-25-000121.md) | [313](/filings/0001514416-26-000035.md) | [345](/filings/0001514416-26-000035.md) | [385](/filings/0001514416-26-000035.md) | [393](/filings/0001514416-26-000035.md) | [400](/filings/0001514416-26-000035.md) | [406](/filings/0001514416-26-000035.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.1 d](/filings/0001514416-24-000140.md) | [23.0 d](/filings/0001514416-24-000173.md) | [19.3 d](/filings/0001514416-26-000017.md) | [2.5](/filings/0001514416-25-000072.md) | [24.4 d](/filings/0001514416-25-000111.md) | [20.5 d](/filings/0001514416-25-000121.md) | [36.5 d](/filings/0001514416-26-000017.md) | [(3.1)](/filings/0001514416-26-000035.md) | [31.7 d](/filings/0001514416-25-000111.md) | [22.2 d](/filings/0001514416-25-000121.md) | [38.6 d](/filings/0001514416-26-000017.md) | [8.8](/filings/0001514416-26-000035.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001514416-26-000035.md) | not reported | not reported | not reported | [5.0](/filings/0001514416-26-000035.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.3](/filings/0001514416-23-000123.md) | [25.3](/filings/0001514416-23-000151.md) | [29.3](/filings/0001514416-24-000083.md) | [25.6](/filings/0001514416-24-000140.md) | [25.6](/filings/0001514416-24-000173.md) | [26.5](/filings/0001514416-25-000072.md) | [29.5](/filings/0001514416-25-000111.md) | [28.6](/filings/0001514416-25-000121.md) | [29.0](/filings/0001514416-26-000035.md) | [29.9](/filings/0001514416-25-000111.md) | [30.3](/filings/0001514416-25-000121.md) | [33.0](/filings/0001514416-26-000035.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.